CRP and metabolic syndrome: A large body of evidence suggests that CRP is closely associated with dyslipidemia, diabetes, cardiovascular disease, and metabolic syndrome, and can be used as an indicator for early screening or long-term monitoring to provide some basis for patient prognosis [18–20].